Clinical trial
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable…
NCT00396214 · Solvay Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00396214 |
|---|---|
| Title | Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients |
| Official title | A Randomized, Multicenter, Double-Blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Collaborators | H. Lundbeck A/S Industry Wyeth is now a wholly owned subsidiary of Pfizer |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Bifeprunox, Quetiapine |
| Enrollment | 83 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Nov 6, 2006 |
| Last update posted | Jun 4, 2008 |
| Countries | Argentina, Canada, Chile, Czechia, Estonia, Finland, Germany, Hungary, Latvia, Lithuania, Peru, Slovakia and 2 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: